These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8800980)

  • 1. Inducible nitric oxide synthase in the cardiovascular system.
    Bhagat K; Vallance P
    Heart; 1996 Mar; 75(3):218-20. PubMed ID: 8800980
    [No Abstract]   [Full Text] [Related]  

  • 2. Substrate supply for nitric-oxide synthase in macrophages and endothelial cells: role of cationic amino acid transporters.
    Closs EI; Scheld JS; Sharafi M; Förstermann U
    Mol Pharmacol; 2000 Jan; 57(1):68-74. PubMed ID: 10617680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the nitric oxide synthase pathway in atherosclerosis.
    Maxwell AJ; Tsao PS; Cooke JP
    Exp Physiol; 1998 Sep; 83(5):573-84. PubMed ID: 9793778
    [No Abstract]   [Full Text] [Related]  

  • 4. The clinical significance of asymmetric dimethylarginine.
    Siroen MP; Teerlink T; Nijveldt RJ; Prins HA; Richir MC; van Leeuwen PA
    Annu Rev Nutr; 2006; 26():203-28. PubMed ID: 16848705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From sodium intake restriction to nitrate supplementation: Different measures with converging mechanistic pathways?
    Clifton P
    Nutr Metab Cardiovasc Dis; 2015 Dec; 25(12):1079-86. PubMed ID: 26614018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor.
    Böger RH; Ron ES
    Altern Med Rev; 2005 Mar; 10(1):14-23. PubMed ID: 15771559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regulation of endothelial NO-synthase expression and vascular endothelium dysfunction in cardiovascular pathology].
    Kravchenko NA; Iarmysh NV
    Tsitol Genet; 2008; 42(4):69-81. PubMed ID: 19140434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The L-arginine-nitric oxide system: physiology, physiopathology and clinical relevance].
    Garini G; Savazzi G; Borghetti A
    Recenti Prog Med; 1997 Feb; 88(2):90-9. PubMed ID: 9148375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-Arginine therapy in cardiovascular pathologies: beneficial or dangerous?
    Böger RH
    Curr Opin Clin Nutr Metab Care; 2008 Jan; 11(1):55-61. PubMed ID: 18090660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atherosclerosis and the two faces of endothelial nitric oxide synthase.
    Wever RM; Lüscher TF; Cosentino F; Rabelink TJ
    Circulation; 1998 Jan 6-13; 97(1):108-12. PubMed ID: 9443438
    [No Abstract]   [Full Text] [Related]  

  • 11. L-arginine availability is not limiting for nitric oxide generation from recombinant endothelial nitric oxide synthase.
    Mohacsi T; Mozes G; Sato J; Gloviczki P; Katusic Z; O'Brien T
    J Vasc Res; 1999; 36(6):437-44; discussion 532-4. PubMed ID: 10629419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosylphosphatidylinositol toxin of Plasmodium induces nitric oxide synthase expression in macrophages and vascular endothelial cells by a protein tyrosine kinase-dependent and protein kinase C-dependent signaling pathway.
    Tachado SD; Gerold P; McConville MJ; Baldwin T; Quilici D; Schwarz RT; Schofield L
    J Immunol; 1996 Mar; 156(5):1897-1907. PubMed ID: 8596042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derangements of the nitric oxide synthase pathway, L-arginine, and cardiovascular diseases.
    Cooke JP; Dzau VJ
    Circulation; 1997 Jul; 96(2):379-82. PubMed ID: 9244195
    [No Abstract]   [Full Text] [Related]  

  • 14. [Nitric oxide. Current findings on the synthesis and genetics of nitric oxide synthases, regulation of hypothalamic and vascular function].
    Dioh A; Hennen G
    Rev Med Liege; 1995 Nov; 50(11):480-6. PubMed ID: 8532995
    [No Abstract]   [Full Text] [Related]  

  • 15. Catecholamines' enhancement of inducible nitric oxide synthase-induced nitric oxide biosynthesis involves CAT-1 and CAT-2A.
    Lin WC; Tsai PS; Huang CJ
    Anesth Analg; 2005 Jul; 101(1):226-32, table of contents. PubMed ID: 15976236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of dysfunction of the nitric oxide pathway in vascular diseases.
    Maxwell AJ
    Nitric Oxide; 2002 Mar; 6(2):101-24. PubMed ID: 11890735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginine metabolism in vascular biology and disease.
    Morris SM
    Vasc Med; 2005 Jul; 10 Suppl 1():S83-7. PubMed ID: 16444873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular biology of nitric oxide synthases. Reduction of complications of cardiopulmonary bypass from platelets and neutrophils by nitric oxide generation from L-arginine and nitric oxide donors.
    Dewanjee MK
    ASAIO J; 1997; 43(3):151-9. PubMed ID: 9152483
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulation of nitric oxide production by arginine metabolic enzymes.
    Mori M; Gotoh T
    Biochem Biophys Res Commun; 2000 Sep; 275(3):715-9. PubMed ID: 10973788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric dimethylarginine: clinical applications in pediatric medicine.
    Tain YL; Huang LT
    J Formos Med Assoc; 2011 Feb; 110(2):70-7. PubMed ID: 21377060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.